The effect of diet-induced, moderate elevation of serum cholesterol on vascular reactivity in isolated rabbit abdominal aortic rings was examined by using a series of vasoconstrictor and vasodilator agonists. Serum The aim of our study was to examine alterations in vascular reactivity in rabbits with moderately elevated serum cholesterol. Our results show that small changes in serum cholesterol depress vasorelaxation to (±)-isoproterenol hydrochloride (ISO) and carbamylcholine chloride (CAR) and enhance vasoconstriction to KCl and 5-hydroxytryptamine (5-HT), suggesting that marked elevation in serum cholesterol and overt pathological changes are not required for altered vascular reactivity.
to block muscarinic receptors. Results of subsequent studies, however, have shown that the addition of these blockers is unnecessary in experiments with rabbit abdominal aorta.
Experimental Protocol
This study was designed to examine vascular reactivity in aortic rings from normal and hypercholesterolemic rabbits using six different contractile agonists: norepinephrine, PGFI,, Ang II, 5-HT, PDBu, and KCl. In addition, the ability of three different relaxants-the endothelium-dependent vasodilator CAR, the P3-adrenergic vasodilator ISO, and the endothelium-independent vasodilator SNP -to relax aortic rings precontracted with a single dose of contractile agonist was assessed. Each tissue was exposed to only one contractile agonist or a combination of one vasoconstrictor and one vasodilator.
All drugs, except PDBu, were prepared fresh daily and dissolved in water. PDBu was dissolved in dimethyl sulfoxide at a concentration of 20 mg/ml and kept frozen. Fresh aliquots were used for each experiment.
Serum Cholesterol Determination
Blood (2 ml) was withdrawn from the ear artery immediately before the rabbits were anesthetized. Total cholesterol in the freshly prepared serum was assayed by using a colorimetric assay kit (No. 352, Sigma) according to manufacturer's instructions. The standard curve was constructed using bovine cholesterol.
Statistics
Differences in responses from normal and hypercholesterolemic tissues were tested for statistical significance using Student's t test. 17 Significance was accepted at the 0.05 level of probability.
Results

Serum Cholesterol Changes
Based on the serum cholesterol determination after 10 weeks of study, rabbits could be easily separated into two groups: group N, control rabbits with normal serum cholesterol (51±5 mg/dl, n=7);
and group H, rabbits with hypercholesteremia (223 ±41 mg/dl, n= 10). Group N included six rabbits that were fed standard lab chow and one rabbit that did not respond to the cholesterol-free, casein-rich diet and exhibited a serum cholesterol level of 70 mg/dl and vascular reactivity similar to the control group. Group H included eight rabbits that were fed the cholesterol-free, casein-rich diet and two rabbits that were fed standard lab chow and exhibited elevated cholesterol levels of 128 and 114 mg/dl, respectively, and vascular reactivity similar to rabbits fed the special diet. Serum cholesterol levels in group H were elevated approximately 4.5-fold above levels in group N. with the various contractile agonists was similar in vessels from both groups of rabbits; however, tension in response to Ang II was significantly higher in group H (Table 1) .
Vascular Reactivity to Vasodilators
In aortic rings from group N that were precontracted with norepinephrine (3 gM, EC90), PGF2a, (10 ,uM, EC75), or 5-HT (10 gM, EC0), CARinduced vasorelaxation was dose dependent and of comparable magnitude, regardless of the constrictor agonist ( Figure 2 ). In vessels from group H, relaxation by CAR was impaired to different extents, depending on the contractile agonist used. In PGF2a-contracted rings, CAR relaxation in group H was almost completely abolished (group N, 44+ 16%; group H, 7+4%; p<0.05) (Figure 2 ). In 5-HTcontracted tissues, maximal relaxation to CAR in vessels from group H was half as great as in group N (group N, 50±12%; group H, 28±10%; p<0.05). Figure  3) . In group H rings, ISO-induced vasorelaxation was impaired. In PGF2a-stimulated rings, ISO-induced relaxation in group H was virtually abolished, whereas in the presence of Ang II or 5 -HT, vessels relaxed 37+12% and 27±14%, respectively.
In tissues precontracted with PDBu as agonist, ISO was ineffective in relaxing vessels from either group, a phenomenon similarly noted with CAR in the presence of PDBu.
The endothelium-independent vasodilator SNP did not affect relaxation in group H compared with group N for all contractile agonists used, except for KCI. In potassium-depolarized tissues, relaxation was significantly enhanced in group H compared with group N (Figure 4) . Discussion The most striking change in vascular reactivity produced by moderate elevation of serum cholesterol was a 30-90% reduction in receptor-mediated muscarinic (CAR) and 13- endothelium-dependent vasodilation in atherosclerotic vessels has been frequently noted,4-1" the serum cholesterol was threefold to fivefold higher than reported here. Similarly, an altered response to ,Badrenergic agonists has been associated with hypercholesterolemia.14,5 However, unlike endothelium-dependent vasorelaxation, reduced ,B-adrenergic vasodilation has not been a consistent finding. '4,15 This is possibly due to the complexity of the ISOinduced response, which at lower doses stimulates vasorelaxation via ,B-adrenergic activation in both endothelial and smooth muscle cells and at higher concentrations induces vasoconstriction by activation of a-adrenergic receptors.18 Therefore, it is possible that the hypercholesterolemia-dependent reduction in ISO-induced vasorelaxation represents a deficiency in an endothelium-dependent mechanism. An additional effect on 18-adrenergic receptor signaling in smooth muscle cannot be ruled out. Our findings suggest that vasodilator mechanisms, especially mediated through an endotheliumdependent or possibly through a 3-adrenergic pathway, are sensitive to relatively small elevations of serum cholesterol.
Additionally, it is emphasized that the opposing vasoconstriction is an important factor in determining the extent of subsequent vasorelaxation. In comparison, an endothelium-independent pathway, mediated by the nitrovasodilator SNP, was not affected by hypercholesterolemia. This is in agreement with another report," in which SNP-induced relaxation was refractory to hypercholesterolemia in the rabbit abdominal aorta.
The mechanism by which modest elevation of cholesterol might inhibit endothelium-dependent effects of CAR and ISO is not clear. In states of severe hypercholesterolemia and in the presence of atherosclerotic plaques, functional alterations of endothelial cells,9 12"19 a diffusion barrier to EDRF,6 and/or intimal trapping of EDRF18 are postulated for reduced endothelium-dependent vasodilatory responses. Additionally, the high activity of cyclic AMP phosphodiesterase in atheromatous lesions20 may explain the reduced response to ISO. In states of minimal increase in serum cholesterol and absence of histologically identifiable plaques (personal communication from Dr. Thomas Hodge, Rorer Central Research, Fort Washington, Pa., on similarly treated groups of rabbits), as in this study, the previously postulated mechanisms may still be present, albeit at reduced levels. Alternatively it is suggested that a general, nonspecific mechanism of cholesterolinduced decrease in membrane fluidity may account for changes observed here. An association between increased extracellular cholesterol, decreased membrane fluidity, and decreased /8-adrenergic responsiveness has previously been documented in a model system of the erythrocyte membrane. '5 Another tension development at a given KCI concentration than in control vessels. 23 In comparison, altered sensitivity to other vasoconstrictors, indicating that increased sensitivity is manifest only at substantially higher serum cholesterol levels, has been shown for norepinephrine,41' clonidine,11 phenylephrine, and Ang 11.20,24 An exception is the dog, in which moderate elevations in serum cholesterol sensitized coronary arteries to both the dilator and constrictor effects of norepinephrine.25 This effect was attributed to a change in the binding characteristics of the a-adrenergic receptor in vascular smooth muscle cells, probably due to a cholesterol-induced increase in the number of membrane a-binding sites.25
Activation of protein kinase C by PDBu so far has not been evaluated in hypercholesterolemia. Differences in vascular sensitivity to PDBu with elevated cholesterol might be expected, given the fact that protein kinase C translocates from the cytosol into the membrane, once activated,26 and that membrane fluidity is influenced by hypercholesterolemic conditions. 15 In our study, however, we did not observe any significant differences in vascular reactivity to PDBu among the two groups. It is possible that the presence of endothelium confounded our results given the observation that 5 -HT-induced vasoconstriction was amplified by short-term exposure of arteries to PDBu and CAR-induced vasorelaxation was decreased.27 In Therefore, although our results suggest that the net vasoconstrictor effect of protein kinase C activation by PDBu is not influenced by minimal changes in serum cholesterol, protein kinase C activation in denuded aortic rings needs to be examined. Therefore, it is premature to conclude that reactivity of protein kinase C is unaffected by minimal changes in serum cholesterol.
In conclusion, aortic rings from rabbits with modest elevation of serum cholesterol displayed markedly decreased vasorelaxation to CAR and ISO. In addition, increased sensitivity to the vasoconstrictors 5-HT and KCl was observed, suggesting that minimal elevation of serum cholesterol in the absence of overt pathological changes is sufficient for altered vascular reactivity.
